RCA Telegram News California - News from San Francisco, California, the USA and the world, around the clock every day

RECENT NEWS

Myanmar civil war drives drugs epidemic in Thai hills
Myanmar civil war drives drugs epidemic in Thai hills

Hundreds of thousands of people in northern Thailand have become collateral damage from the civil war in neighbouring Myanmar, turning to drugs as supply through the area rockets on the back of the conflict.

March 10, 2026

AI offers hope for young filmmakers dreaming of an Oscar
AI offers hope for young filmmakers dreaming of an Oscar

Studying at the film school where Oscar-nominated "Sinners" director Ryan Coogler honed his craft, SiJia Zheng dreams of winning an Academy Award.

March 10, 2026

Viral drone video fuels debate about Rio favela tourism
Viral drone video fuels debate about Rio favela tourism

A line of tourists touch up their makeup before strutting across a rooftop in Rio de Janeiro's largest favela, posing for a drone as it zooms out to show dramatic aerial views of the hillside community.

March 10, 2026

RECENT NEWS

Zeus North America Mining Corp. Announces Closing of First Tranche of Private Placement
Zeus North America Mining Corp. Announces Closing of First Tranche of Private Placement

VANCOUVER, BC / ACCESS Newswire / March 10, 2026 / ZEUS NORTH AMERICA MINING CORP. (CSE:ZEUS)(OTCQB:ZUUZF)(FRANKFURT:O92) (THE "COMPANY" OR "ZEUS") is pleased to announce that it has closed the first tranche of its previously announced non-brokered private placement (the "Placement") through the issuance of 21,720,000 units ("Units") at a price of $0.10 per Unit for gross proceeds of $2,172,000.

March 10, 2026

RECENT NEWS

CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth
CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth

SAN DIEGO, CA / ACCESS Newswire / March 10, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in proven, science-backed natural ingredients and products, today announced that it has modified its existing outstanding notes to include a conversion feature pursuant to which the outstanding balance of the notes may be converted into common shares of the Company at a fixed conversion price of $0.06 per share.

March 10, 2026